Variant report

Variant	esv3328158
Chromosome Location	chr8:105477801-105480349
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:13)
CpG islands
(count:734)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:13 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr8:105478880-105479030	HRE	kidney:	n/a	n/a
2	CTCF	chr8:105478880-105479030	HBMEC	blood vessel:	n/a	n/a
3	CTCF	chr8:105478940-105479090	HRPEpiC	eye:	n/a	n/a
4	CTCF	chr8:105478940-105479090	AG09319	gingival:	n/a	n/a
5	CTCF	chr8:105478960-105479110	HCM	heart:	n/a	n/a
6	CTCF	chr8:105478940-105479090	HPAF	blood vessel:	n/a	n/a
7	CTCF	chr8:105478920-105479070	HAc	cerebellar:	n/a	n/a
8	CTCF	chr8:105478920-105479070	HUVEC	blood vessel:	n/a	n/a
9	CTCF	chr8:105479032-105479086	NHEK	skin:	n/a	n/a
10	CTCF	chr8:105478960-105479110	AG04449	skin:	n/a	n/a
11	CTCF	chr8:105478899-105479155	Fibrobl	skin:	n/a	n/a
12	E2F6	chr8:105478867-105478973	K562	blood:	n/a	n/a
13	MAX	chr8:105478929-105479079	HepG2	liver:	n/a	n/a

(count:734 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:105479862-105479912	NH-A	brain:	n/a
2	chr8:105479674-105479724	HNPCEpiC	eye:	n/a
3	chr8:105479862-105479912	NH-A	brain:	n/a
4	chr8:105479674-105479724	HNPCEpiC	eye:	n/a
5	chr8:105479383-105479433	GM12891	blood:	n/a
6	chr8:105479058-105479108	SK-N-SH	brain:	n/a
7	chr8:105479058-105479108	HCPEpiC	choroid plexus:	n/a
8	chr8:105479058-105479108	H1-hESC	embryonic stem cell:	embryo
9	chr8:105478855-105478905	HepG2	liver:	n/a
10	chr8:105479705-105479755	AoSMC	blood vessel:	n/a
11	chr8:105479674-105479724	GM12892	blood:	n/a
12	chr8:105479248-105479298	HMEC	breast:	n/a
13	chr8:105479862-105479912	Hela-S3	cervix:	n/a
14	chr8:105478683-105478733	ovcar-3	ovarian:	n/a
15	chr8:105479674-105479724	HEK293	kidney:	embryo
16	chr8:105479367-105479417	ProgFib	skin:	n/a
17	chr8:105479215-105479265	AG10803	skin:	n/a
18	chr8:105479674-105479724	RPTEC	kidney:	n/a
19	chr8:105479215-105479265	Caco-2	colon:	n/a
20	chr8:105479383-105479433	AG09319	gingival:	n/a
21	chr8:105479420-105479470	AG09319	gingival:	n/a
22	chr8:105479248-105479298	A549	lung:	n/a
23	chr8:105479318-105479368	H1-hESC	embryonic stem cell:	embryo
24	chr8:105479420-105479470	HCT-116	colon:	n/a
25	chr8:105479674-105479724	NB4	blood:	n/a
26	chr8:105479058-105479108	HAEpiC	amniotic membrane:	n/a
27	chr8:105479318-105479368	NHDF-neo	bronchial:	n/a
28	chr8:105479420-105479470	HEEpiC	esophagus:	n/a
29	chr8:105479420-105479470	PrEC	prostate:	n/a
30	chr8:105479862-105479912	HL-60	blood:	n/a
31	chr8:105479058-105479108	PFSK-1	brain:	n/a
32	chr8:105479674-105479724	Jurkat	blood:	n/a
33	chr8:105479248-105479298	HCF	heart:	n/a
34	chr8:105478855-105478905	HEEpiC	esophagus:	n/a
35	chr8:105479058-105479108	SK-N-MC	brain:	n/a
36	chr8:105479248-105479298	AG09319	gingival:	n/a
37	chr8:105479058-105479108	BJ	skin:	n/a
38	chr8:105479383-105479433	H1-hESC	embryonic stem cell:	embryo
39	chr8:105479705-105479755	NT2-D1	testis:	n/a
40	chr8:105478683-105478733	Jurkat	blood:	n/a
41	chr8:105478855-105478905	AoSMC	blood vessel:	n/a
42	chr8:105479674-105479724	HAEpiC	amniotic membrane:	n/a
43	chr8:105479318-105479368	SK-N-SH	brain:	n/a
44	chr8:105478683-105478733	NHDF-neo	bronchial:	n/a
45	chr8:105479058-105479108	NH-A	brain:	n/a
46	chr8:105479248-105479298	HIPEpiC	eye:	n/a
47	chr8:105479367-105479417	IMR90	lung:	fetal
48	chr8:105479248-105479298	ECC-1	luminal epithelium:	n/a
49	chr8:105479674-105479724	PANC-1	pancreas:	n/a
50	chr8:105478683-105478733	NB4	blood:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:105480325..105482906-chr8:105485339..105487035,2	K562	blood:
2	chr8:105480325..105482221-chr8:105484605..105486839,2	K562	blood:
3	chr8:105468587..105471783-chr8:105476013..105478836,3	K562	blood:

No data

Variant related genes	Relation type
DPYS	TF binding region
DPYS	CpG island

Extended variants
information (count: 88 )
Associated
traits (count: 114 )

Variant overlapped rSNPs/rCNVs (count:88 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs530269522	chr8:105477850-105477851	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs73293244	chr8:105477857-105477858	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs77950150	chr8:105477891-105477892	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs371135449	chr8:105477893-105477894	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs533577819	chr8:105477906-105477907	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs370473920	chr8:105478003-105478004	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs76274329	chr8:105478032-105478033	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs570088155	chr8:105478061-105478062	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs537519023	chr8:105478090-105478091	Weak transcription Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs146604601	chr8:105478215-105478216	Weak transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs370342411	chr8:105478222-105478223	Weak transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs113689411	chr8:105478226-105478227	Weak transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs550085744	chr8:105478228-105478229	Weak transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs574547534	chr8:105478249-105478250	Weak transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs570006862	chr8:105478276-105478277	Weak transcription Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs6997991	chr8:105478405-105478406	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs553820024	chr8:105478496-105478497	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs184449793	chr8:105478579-105478580	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs540659284	chr8:105478605-105478606	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs148394148	chr8:105478615-105478616	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs142574986	chr8:105478628-105478629	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs544387655	chr8:105478677-105478678	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs562997435	chr8:105478678-105478679	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs530272695	chr8:105478691-105478692	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs2298841	chr8:105478699-105478700	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs566852201	chr8:105478720-105478721	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528003763	chr8:105478750-105478751	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs557198464	chr8:105478793-105478794	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs189294405	chr8:105478851-105478852	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
30	rs552354398	chr8:105478855-105478856	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
31	rs138820185	chr8:105478871-105478872	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
32	rs2298840	chr8:105478933-105478934	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs370718225	chr8:105478940-105478941	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
34	rs568135080	chr8:105478972-105478973	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
35	rs535322008	chr8:105478981-105478982	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
36	rs375043330	chr8:105478990-105478991	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
37	rs553987375	chr8:105479009-105479010	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
38	rs367711099	chr8:105479018-105479019	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
39	rs370264718	chr8:105479038-105479039	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
40	rs376340504	chr8:105479044-105479045	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
41	rs368590087	chr8:105479059-105479060	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
42	rs572241599	chr8:105479101-105479102	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
43	rs546133393	chr8:105479118-105479119	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
44	rs199966726	chr8:105479120-105479121	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs57732538	chr8:105479130-105479131	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs199618701	chr8:105479132-105479133	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs182332679	chr8:105479134-105479135	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs2959023	chr8:105479149-105479150	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs530188131	chr8:105479184-105479185	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs541934140	chr8:105479252-105479253	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:114)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Testicular cancer	18059402	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
abnormal development	18461090	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	16751803	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Multiple myeloma	16461302	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	21399628	CNVD
small cell lung cancer	20016488	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	17393978	CNVD
Burkitt''s lymphoma	18698080	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Bladder cancer	19088036	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17899364	CNVD
Acute myeloid leukemia	21251322	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17170743	CNVD
Colorectal cancer	16774939	CNVD
Autosomal-dominant progressive external ophthalmoplegia	19664747	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Sezary syndrome	18413736	CNVD
Urothelial cell carcinoma	18451213	CNVD
Colorectal cancer	21645411	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	16912164	CNVD
Breast cancer	20409316	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Breast cancer	21611746	CNVD
Developmental delay	21147756	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Oral squamous cell carcinoma	21853135	CNVD
Prostate cancer	22341455	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:140 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:105469600-105478600	Weak transcription	Pancreas	Pancrea
2	chr8:105473400-105478800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr8:105477600-105478800	Bivalent/Poised TSS	Fetal Kidney	kidney
4	chr8:105477600-105479400	Active TSS	Liver	Liver
5	chr8:105478200-105478600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr8:105478200-105478600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr8:105478200-105478600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr8:105478400-105478800	Bivalent Enhancer	Fetal Stomach	stomach
9	chr8:105478400-105479000	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
10	chr8:105478400-105479400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
11	chr8:105478400-105479600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
12	chr8:105478400-105479600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
13	chr8:105478400-105479600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
14	chr8:105478400-105479600	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr8:105478600-105478800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr8:105478600-105478800	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr8:105478600-105478800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr8:105478600-105478800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
19	chr8:105478600-105478800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr8:105478600-105478800	Enhancers	Adipose Nuclei	Adipose
21	chr8:105478600-105478800	Bivalent Enhancer	Brain Anterior Caudate	brain
22	chr8:105478600-105478800	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
23	chr8:105478600-105478800	Enhancers	Colonic Mucosa	Colon
24	chr8:105478600-105478800	Bivalent Enhancer	Fetal Thymus	thymus
25	chr8:105478600-105478800	Enhancers	Pancreas	Pancrea
26	chr8:105478600-105478800	Flanking Bivalent TSS/Enh	Placenta Amnion	Placenta Amnion
27	chr8:105478600-105478800	Active TSS	Right Atrium	heart
28	chr8:105478600-105478800	Flanking Active TSS	Right Ventricle	heart
29	chr8:105478600-105478800	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
30	chr8:105478600-105479000	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
31	chr8:105478600-105479000	Bivalent Enhancer	Primary hematopoietic stem cells	blood
32	chr8:105478600-105479000	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
33	chr8:105478600-105479000	Bivalent Enhancer	Fetal Heart	heart
34	chr8:105478600-105479200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr8:105478600-105479200	Bivalent Enhancer	Esophagus	oesophagus
36	chr8:105478600-105479200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
37	chr8:105478600-105479400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
38	chr8:105478600-105479400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
39	chr8:105478600-105479400	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr8:105478600-105479400	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
41	chr8:105478600-105479400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr8:105478600-105479400	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
43	chr8:105478600-105479400	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr8:105478600-105479400	Bivalent/Poised TSS	Brain Germinal Matrix	brain
45	chr8:105478600-105479400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
46	chr8:105478600-105479400	Bivalent/Poised TSS	Fetal Brain Female	brain
47	chr8:105478600-105479400	Active TSS	Ovary	ovary
48	chr8:105478600-105479400	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
49	chr8:105478600-105479400	Bivalent/Poised TSS	Thymus	Thymus
50	chr8:105478600-105479400	Bivalent/Poised TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links